New eczema cream shows promise in early trial
NCT ID NCT07182864
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tested an experimental ointment called MH004 in 160 healthy adults and people with mild to moderate eczema. The goal was to see if it is safe and can reduce skin symptoms like redness and itching. Participants applied the ointment for up to 4 weeks, and researchers measured changes in eczema severity using a standard scoring system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.